Related Experiment Video
Updated: May 19, 2026
08:43
A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Radiation therapy for vestibular schwannomas
Jef J S Mulder1, Johannes H Kaanders, Jacobus J van Overbeeke
1Department of Otolaryngology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. j.mulder@kno.umcn.nl
Current Opinion in Otolaryngology & Head and Neck Surgery
|August 31, 2012
Summary
Vestibular schwannoma growth is infrequent; radiotherapy, including stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), offers high tumor control with minimal side effects. Future research should clarify optimal treatment timing.
Area of Science:
- Neuro-oncology
- Radiation Oncology
Background:
- Vestibular schwannomas are tumors that can affect hearing and balance.
- Understanding their natural course and treatment outcomes is crucial for patient management.
Purpose of the Study:
- To review recent literature on the natural history of vestibular schwannomas.
- To summarize current insights into radiotherapy outcomes for these tumors.
Main Methods:
- Systematic review of recent publications.
- Analysis of data on tumor progression, radiotherapy efficacy, and side effects.
Main Results:
- Approximately one-third of vestibular schwannomas progress after diagnosis.
- Radiotherapy (SRS/FSRT) achieves high tumor control (95%) with low toxicity.
- Hearing preservation data is evolving, prompting re-evaluation of watchful waiting.
Conclusions:
- Radiotherapy (SRS or FSRT) is effective for growing vestibular schwannomas.
- Further research is needed to determine optimal treatment indications and long-term effects of different radiotherapy techniques.
